Leerink initiates Entera Bio coverage with Outperform and $9 target
Leerink Partners initiated coverage on Entera Bio with an Outperform rating and a $9.00 price target. The target implies 197.0% upside versus the Sep 17 close of $3.03.
Story updates
01:29:29 PM UTC
SquawkNews
Entera Bio Price Target Announced at $9.00/Share by Leerink Partners
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.